Ryan Reynolds on his 'complicated' relationship with his dad, how it's changed him [USA TODAY]
ACADIA Pharmaceuticals Inc. (ACAD)
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
Company Research
Source: USA TODAY
to the illness, the second-most common neurological disease behind . Ryan has long been a part of the fight for Parkinson's awareness, and is furthering that effort by announcing a new campaign, " ," in partnership with Acadia Pharmaceuticals. Parkinson's is a that worsens over time and is incurable, affecting in the United States. Patients lose dopamine-producing brain cells important for normal movement. Symptoms include everything from speech changes to impaired balance and stiff muscles, though the severity varies by person. The goal of "More too Parkinson's?" To teach caregivers, patients and care providers about an aspect of the disease no one talks about that much: Parkinson's-related hallucinations and delusions. About half of those who have Parkinson's may have hallucinations or delusions as their disease progresses (the cause is unknown), though they may present differently for each person. And most don't share these details with their doctors. "It's something I had no
Show less
Read more
Impact Snapshot
Event Time:
ACAD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACAD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACAD alerts
High impacting ACADIA Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
ACAD
News
- Axcelead Drug Discovery Partners Enters into Master Service Agreement for Drug Discovery Projects with Acadia Pharmaceuticals [Yahoo! Finance]Yahoo! Finance
- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Acadia Pharmaceuticals to Participate at Upcoming Investor ConferencesBusiness Wire
- Acadia Pharmaceuticals: Nuplazid Performs In Q2 While Daybue Disappoints Again [Seeking Alpha]Seeking Alpha
- Ryan Reynolds Announces More to Parkinson’s® CampaignBusiness Wire
ACAD
Earnings
- 8/6/24 - Beat
ACAD
Sec Filings
- 8/20/24 - Form 4
- 8/20/24 - Form 4
- 8/20/24 - Form 4
- ACAD's page on the SEC website